These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 4925984

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vascular disease in systemic sclerosis.
    Poredos P.
    Vasa; 2011 Jan; 40(1):3-4. PubMed ID: 21375075
    [No Abstract] [Full Text] [Related]

  • 3. Endothelin and collagen vascular disease: a review with special reference to Raynaud's phenomenon and systemic sclerosis.
    Yamane K.
    Intern Med; 1994 Oct; 33(10):579-82. PubMed ID: 7827371
    [Abstract] [Full Text] [Related]

  • 4. Advances in the diagnosis and management of scleroderma-related vascular complications.
    Kerin K, Yost JH.
    Compr Ther; 1998 Oct; 24(11-12):574-81. PubMed ID: 9847974
    [Abstract] [Full Text] [Related]

  • 5. The spectrum of scleroderma (II).
    LeRoy EC, Lomeo R.
    Hosp Pract (Off Ed); 1989 Nov 15; 24(11):65-8, 69-72, 75-6 passim. PubMed ID: 2509504
    [No Abstract] [Full Text] [Related]

  • 6. Pulmonary artery hypertension as the presenting feature of systemic sclerosis sine scleroderma.
    Pauling JD, Gunawardena H, Coghlan JG, Easaw J, Suntharalingam J, McHugh NJ.
    Rheumatology (Oxford); 2008 Sep 15; 47(9):1431-2. PubMed ID: 18603658
    [No Abstract] [Full Text] [Related]

  • 7. Systemic sclerosis - a systematic overview: part 1 - disease characteristics and classification, pathophysiologic concepts, and recommendations for diagnosis and surveillance.
    Klein-Weigel P, Opitz C, Riemekasten G.
    Vasa; 2011 Jan 15; 40(1):6-19. PubMed ID: 21283969
    [Abstract] [Full Text] [Related]

  • 8. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
    LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F.
    J Rheumatol; 1988 Feb 15; 15(2):202-5. PubMed ID: 3361530
    [No Abstract] [Full Text] [Related]

  • 9. Care of patients with scleroderma in the intensive care setting.
    Farber HW, Simms RW, Lafyatis R.
    J Intensive Care Med; 2010 Sep 15; 25(5):247-58. PubMed ID: 20542965
    [Abstract] [Full Text] [Related]

  • 10. Management of systemic sclerosis.
    Lim IG, Schrieber L.
    Isr Med Assoc J; 2002 Nov 15; 4(11 Suppl):953-7. PubMed ID: 12455189
    [No Abstract] [Full Text] [Related]

  • 11. [Pathogenic mechanisms in systemic sclerosis and their therapeutical consequences. Part 2: treatment].
    Zuber JP, Chizzolini C, Leimgruber A, Bart PA, Spertini F.
    Rev Med Suisse; 2006 Apr 19; 2(62):1058, 1060-6. PubMed ID: 16711151
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis and management of vascular disease in systemic sclerosis.
    Yost JH, Spencer-Green G.
    Compr Ther; 1993 Apr 19; 19(2):53-9. PubMed ID: 8370246
    [Abstract] [Full Text] [Related]

  • 13. Clinical aspects of systemic sclerosis (scleroderma).
    Silver RM.
    Ann Rheum Dis; 1991 Nov 19; 50 Suppl 4(Suppl 4):854-61. PubMed ID: 1750797
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Scleroderma--a vascular disease].
    Keplan D.
    Ter Arkh; 1978 Nov 19; 50(9):102-4. PubMed ID: 705638
    [No Abstract] [Full Text] [Related]

  • 16. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
    Wigley FM.
    Curr Opin Rheumatol; 1996 Nov 19; 8(6):561-8. PubMed ID: 9018460
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pulmonary hypertension.
    Tektonidou M.
    N Engl J Med; 2005 Jan 27; 352(4):418-9; author reply 418-9. PubMed ID: 15675104
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.